Literature DB >> 28317984

Stabilizing the monomeric amyloid-β peptide by tyrocidine A prevents and reverses amyloidogenesis without the accumulation of oligomers.

Gesi Wen1, Wenjing Qin1, Daoyuan Chen1, Youqiao Wang1, Xin Yue1, Ziyi Liu1, Yingnan Cao2, Jun Du1, Binhua Zhou1, Xianzhang Bu1.   

Abstract

Amyloid-β (Aβ) oligomers are causative agents triggering AD pathogenesis, but their elimination remains challenging. We herein reported a natural cyclopeptide tyrocidine A prevents and reverses amyloidogenesis without Aβ oligomer accumulation by stabilizing the monomeric, but not the oligomeric state of Aβ peptides.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28317984     DOI: 10.1039/c7cc00506g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

Review 1.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

2.  Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation.

Authors:  Tao Yang; Zhenzhu Zhu; Enmao Yin; Yanqing Wang; Changli Zhang; Hao Yuan; Hongmei Zhang; Suxing Jin; Zijian Guo; Xiaoyong Wang
Journal:  Chem Sci       Date:  2019-09-19       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.